Huntington's Disease Society of America’s Post

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease. Visit https://lnkd.in/ey6mFkCv for full press release. #Huntingtonsdisease #HDResearch #partofthefamily #familyiseverything

  • No alternative text description for this image
Lana Garafola

Executive Medical Director at Sage Therapeutics

2w

Wonderful news, congratulations to the team!

To view or add a comment, sign in

Explore topics